Judges Scientific, the London-listed maker of precision instruments, has announced impressive results for the first half of 2023. The company experienced a significant increase in both revenue and orders, positioning it well within the market.
For the six-month period ending on June 30, Judges Scientific’s organic revenue showcased a remarkable 17% growth compared to the previous year. This positive development reflects the company’s successful efforts in addressing supply-chain challenges and capitalizing on a surge in order intake.
Furthermore, organic order intake rose by an impressive 14% compared to the first half of 2022, showing a remarkable 23% increase from pre-pandemic levels in 2019. This growth was prevalent across all major regions, portraying Judges Scientific’s global appeal and vitality.
While the exact figures were not disclosed, the board expressed confidence in achieving market expectations for the full year. This optimism is supported by a robust current order book and the overall resilience of the company’s businesses.
Shares of Judges Scientific saw a rise of 1.8% at 9,260.0 pence at 0732 GMT, indicating positive investor sentiment and recognition of the company’s success.
In summary, Judges Scientific has demonstrated solid growth in revenue and orders in the first half of 2023. With its strong market position and continued resilience, the company is poised for continued success in the future.
